IP Library Granted Patent US 8,044,026
Granted Patent B2
US 8,044,026 · App. 12/700,644 · Granted Oct 25, 2011

Composition for promoting cartilage formation or repair comprising a NELL gene product and method of treating cartilage-related conditions using such composition

Assignee: The Regents of the University of California
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,044,026
App. No.
12/700,644
Granted
Oct 25, 2011
Kind
B2
Abstract

Provided herein are a composition for promoting cartilage formation or regeneration comprising a NELL gene product and a method of treating cartilage-related conditions using such a composition.

Claims (35)

1. A composition for promoting cartilage formation or repair, comprising a NELL peptide, wherein the NELL peptide is in an effective amount for cartilage formation or repair,

wherein the NELL peptide comprises SEQ ID NO: 2, 4, or 6 or a fragment of SEQ ID NO: 2, 4, or 6; and

wherein the composition is in an implantable formulation so as to promote cartilage formation or repair.

2. The composition of claim 1 , further comprising a second agent.

3. The composition of claim 1 , further comprising a second agent selected from the group consisting of chondroprotective agents, anti-pain and/or anti-inflammatory agents, growth factors, cytokines, small molecules, anti-angiogenic factors and combinations thereof.

4. The composition of claim 1 , further comprising a pharmaceutically acceptable carrier.

5. The composition of claim 2 , further comprising a pharmaceutically acceptable carrier.

6. The composition of claim 1 , further comprising a material that comprises a chemical gel, a physical gel, an interpenetrating network, or a crosslinker.

7. The composition of claim 1 in an injectable or moldable formulation that sets upon application to a site in a body part of a human being.

8. The composition of claim 1 , further comprising a material that degrades or releases the NELL peptide in response to a stimulus.

9. The composition of claim 8 , wherein the stimulus is selected from mechanical stimuli, light, electromagnetic field, temperature changes, pH changes, or changes of ionic strength.

10. The composition of claim 1 , further comprising an osteochondroprogenitor cell.

11. The composition of claim 1 , further comprising an osteochondroprogenitor cell selected from mesenchymal cells, fetal embryonic cells, stem cells, bone marrow cells, adipose stem cells, fibroblasts, or combinations thereof.

12. The composition of claim 1 , further comprising a chondrogenic cell.

13. The composition of claim 1 , wherein cartilage formation or repair is formation or repair of hyaline or tracheal cartilage, elastic cartilage, or fibrocartilage.

14. The composition of claim 1 , formulated into a device.

15. The composition of claim 1 , wherein the NELL peptide is in an amount effective for treating, or ameliorating a cartilage related disorder.

16. The composition of claim 15 , wherein the cartilage related disorder is arthropathies of various joints, arthritis of various joints, internal cartilage derangements of various joints, or spinal joint and disc-related disorders.

17. An implant for use in the human body comprising a substrate having a surface, wherein at least a portion of the surface includes a composition according to claim 1 .

18. An implant for use in the human body comprising a substrate having a surface, wherein at least a portion of the surface includes a composition according to claim 2 .

19. An implant for use in the human body comprising a substrate having a surface, wherein at least a portion of the surface includes a composition according to claim 3 .

20. An implant for use in the human body comprising a substrate having a surface, wherein at least a portion of the surface includes a composition according to claim 4 .

21. An implant for use in the human body comprising a substrate having a surface, wherein at least a portion of the surface includes a composition according to claim 5 .

22. An implant for use in the human body comprising a substrate having a surface, wherein at least a portion of the surface includes a composition according to claim 10 .

23. The implant of claim 17 , wherein the substrate is resorbable.

24. The implant of claim 17 , wherein the substrate comprises collagen.

25. The implant of claim 18 , wherein the substrate is resorbable.

26. The implant of claim 18 , wherein the substrate comprises collagen.

27. The implant of claim 17 , which is a device selected from:

an injectable/implantable device containing NELL protein with or without cells that can be directly injected or implanted into a spinal disc to promote cartilage formation;

a disc nucleus replacement device impregnated with NELL that is designed to replace the inner portion of a vertebral disc or both the inner and outer portion of a vertebral disc;

an injectable/implantable device containing NELL with or without cells that can be directly injected into various joint spaces or implanted arthroscopically or openly into various joint spaces;

an injectable/implantable device containing NELL protein with or without cells and other factors that can be directly injected/implanted into a spinal disc to promote cartilage formation;

a disc nucleus replacement device impregnated with NELL and other factors that is designed to replace the inner portion of a vertebral disc or both the inner and outer portion of a vertebral disc; or

an injectable/implantable device containing NELL and other factors with or without cells that can be directly injected into various joint spaces or implanted arthroscopically or openly into various joint spaces.

Assignments (2)
CONFIRMATORY LICENSE Recorded Nov 12, 2015
From: UNIVERSITY OF CALIFORNIA LOS ANGELES
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 037104/0113 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 21, 2011
From: TING, KANG; WU, BEN; SOO, CHIA
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 026944/0797 →
Continuity (9)
Division 11594510 · Nov 7, 2006
Continuation In Part 10527786
Continuation In Part 10544553
Continuation In Part PCTUS2006005473 · Feb 16, 2006
Continuation In Part 11392294 · Mar 28, 2006
Provisional Application 60410846 · Sep 13, 2002
Provisional Application 60445672 · Feb 7, 2003
Provisional Application 60653722 · Feb 16, 2005
Related Publication 20100136087A1 · Jun 3, 2010